{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:33:32Z","timestamp":1793885612116,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK123704"],"award-info":[{"award-number":["P30 DK123704"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX006016"],"award-info":[{"award-number":["I01BX006016"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM130457"],"award-info":[{"award-number":["P20 GM130457"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.amjmed.2026.09.008","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:59:34Z","timestamp":1790866774000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Normal alanine aminotransferase levels underestimate the burden of steatotic liver disease and fibrosis in US adults"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-9349","authenticated-orcid":false,"given":"Jad","family":"Allam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-4986","authenticated-orcid":false,"given":"Paul","family":"Nietert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-2961","authenticated-orcid":false,"given":"Don C.","family":"Rockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.amjmed.2026.09.008_bib0001","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients","volume":"342","author":"Pratt","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjmed.2026.09.008_bib0002","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MOG.0000000000001094","article-title":"Aminotransferase levels in clinical practice - what is normal?","volume":"41","author":"Allam","year":"2025","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.008_bib0003","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG Clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjmed.2026.09.008_bib0004","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1440-1746.2012.07143.x","article-title":"Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea","volume":"28","author":"Sohn","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.amjmed.2026.09.008_bib0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2036.2012.05224.x","article-title":"Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects","volume":"36","author":"Wu","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.amjmed.2026.09.008_bib0006","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep4.1794","article-title":"Definition of healthy ranges for Alanine aminotransferase levels: a 2021 update","volume":"5","author":"Valenti","year":"2021","journal-title":"Hepatol Commun"},{"issue":"8","key":"10.1016\/j.amjmed.2026.09.008_bib0007","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/apt.17914","article-title":"Upper limit of normal ALT levels in health and metabolic diseases: pooled analysis of 423,355 individuals with bootstrap modelling","volume":"59","author":"Tan","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.amjmed.2026.09.008_bib0008","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s10620-013-2659-0","article-title":"Revising the upper limit of normal for levels of serum alanine aminotransferase in a Middle Eastern population with normal liver histology","volume":"58","author":"Al-hamoudi","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.008_bib0009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1172\/JCI103055","article-title":"Transaminase activity in human blood","volume":"34","author":"Karmen","year":"1955","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.amjmed.2026.09.008_bib0010","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/jcp.43.11.929","article-title":"Serum alanine transaminase (ALT) reference ranges estimated from blood donors","volume":"43","author":"Goldie","year":"1990","journal-title":"J Clin Pathol"},{"issue":"17","key":"10.1016\/j.amjmed.2026.09.008_bib0011","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198104233041701","article-title":"Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study","volume":"304","author":"Aach","year":"1981","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjmed.2026.09.008_bib0012","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/oxfordjournals.aje.a113380","article-title":"The distribution of serum alanine aminotransferase levels in a blood donor population","volume":"115","author":"Kahn","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.amjmed.2026.09.008_bib0013","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-107-2-137","article-title":"Evaluation of blood donors with elevated serum alanine aminotransferase levels","volume":"107","author":"Friedman","year":"1987","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.amjmed.2026.09.008_bib0014","first-page":"913","article-title":"Hepatitis C virus RNA and liver histology in blood donors reactive to a single antigen by second-generation recombinant immunoblot assay","volume":"21","author":"Zanella","year":"1995","journal-title":"Hepatology"},{"issue":"8237","key":"10.1016\/j.amjmed.2026.09.008_bib0015","first-page":"73","volume":"2","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.amjmed.2026.09.008_bib0016","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.510270505","article-title":"Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC group","volume":"27","author":"Piton","year":"1998","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.008_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.amjmed.2026.09.008_bib0018","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3748\/wjg.v9.i10.2322","article-title":"Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors","volume":"9","author":"Mohamadnejad","year":"2003","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.amjmed.2026.09.008_bib0019","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1478-3231.2006.01197.x","article-title":"Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study","volume":"26","author":"Kariv","year":"2006","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.008_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15171\/mejdd.2020.159","article-title":"Upper normal limit of serum alanine aminotransferase and its association with metabolic risk factors in pars cohort study","volume":"12","author":"Sehatpour","year":"2020","journal-title":"Middle East J Dig Dis"},{"issue":"5","key":"10.1016\/j.amjmed.2026.09.008_bib0021","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.23505","article-title":"Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology","volume":"51","author":"Lee","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.amjmed.2026.09.008_bib0022","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1478-3231.2010.02371.x","article-title":"Subjects with sonographical hepatic steatosis should be excluded from studies to establish upper reference levels of serum transaminases","volume":"31","author":"V\u00f6lzke","year":"2011","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.amjmed.2026.09.008_bib0023","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/hepr.12293","article-title":"Upper limit of normal serum alanine aminotransferase levels in Japanese subjects","volume":"44","author":"Tanaka","year":"2014","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.amjmed.2026.09.008_bib0024","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1440-1746.2010.06481.x","article-title":"Healthy range for serum ALT and the clinical significance of \"unhealthy\" normal ALT levels in the Korean population","volume":"26","author":"Kang","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.amjmed.2026.09.008_bib0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hep.24725","article-title":"Upper limits of normal for alanine aminotransferase activity in the United States population","volume":"55","author":"Ruhl","year":"2012","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.amjmed.2026.09.008_bib0026","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/jcm8091445","article-title":"Low alanine aminotransferase cut-off for predicting liver outcomes; A nationwide population-based longitudinal cohort study","volume":"8","author":"Park","year":"2019","journal-title":"J Clin Med"},{"issue":"7446","key":"10.1016\/j.amjmed.2026.09.008_bib0027","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.38050.593634.63","article-title":"Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study","volume":"328","author":"Kim","year":"2004","journal-title":"Bmj"},{"issue":"5","key":"10.1016\/j.amjmed.2026.09.008_bib0028","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.008_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.amjmed.2026.09.008_bib0031","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American association for the study of liver diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.amjmed.2026.09.008_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2023.11.003","article-title":"Prevalence of steatotic liver disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020","volume":"22","author":"Kalligeros","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.amjmed.2026.09.008_bib0033","first-page":"670","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease, high-risk nonalcoholic steatohepatitis, and fibrosis among lean United States adults: NHANES 2017-2020","volume":"36","author":"Kalligeros","year":"2023","journal-title":"Ann Gastroenterol"},{"issue":"11","key":"10.1016\/j.amjmed.2026.09.008_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2023.02.013","article-title":"Sarcopenia among patients with nonalcoholic fatty liver disease (NAFLD) is associated with advanced fibrosis","volume":"21","author":"Harring","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.09.008_bib0035","article-title":"New insights into metabolic dysfunction-associated steatotic liver disease and oxidative balance score","volume":"10","author":"Peng","year":"2023","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.amjmed.2026.09.008_bib0036","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.amjmed.2026.09.008_bib0037","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1440-1746.2010.06369.x","article-title":"Large-scale population analysis reveals an extremely low threshold for \"non-healthy\" alanine aminotransferase that predicts diabetes mellitus","volume":"25","author":"Shlomai","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.09.008_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100644","article-title":"Higher serum alanine aminotransferase levels and the incidence of hypertension: the Kailuan cohort study","volume":"17","author":"Jia","year":"2024","journal-title":"Am J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.amjmed.2026.09.008_bib0039","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2008.09.018","article-title":"Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease","volume":"135","author":"Goessling","year":"2008","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.amjmed.2026.09.008_bib0040","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.08.036","article-title":"Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis","volume":"145","author":"Siddiqui","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.amjmed.2026.09.008_bib0041","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00125-012-2826-4","article-title":"The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the insulin resistance atherosclerosis study","volume":"56","author":"Lorenzo","year":"2013","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.amjmed.2026.09.008_bib0042","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/HEP.0000000000000843","article-title":"AASLD Practice guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326006698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326006698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:10:08Z","timestamp":1793884208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934326006698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S0002934326006698"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.09.008","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normal alanine aminotransferase levels underestimate the burden of steatotic liver disease and fibrosis in US adults","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}